Transcripts Takeda Pharmaceutical Company Limited London S.E.

Equities

0A87

US8740602052

Market Closed - London S.E. Other stock markets 10:28:32 2024-05-23 EDT			5-day change	1st Jan Change
13.07 ^USD	+0.12%		-3.04%	-8.12%

06-14	Takeda Signs Option Agreement with Ascentage to License Leukemia Drug	MT
06-14	Takeda Pharmaceutical Company Limited Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, Third-Generation BCR-ABL Tyrosine Kinase Inhibitor	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Takeda Pharmaceutical Company Limited - Special Call	06-03
Transcript : Takeda Pharmaceutical Company Limited, 2024 Earnings Call, May 09, 2024	05-09
Transcript : Takeda Pharmaceutical Company Limited, Q3 2024 Earnings Call, Feb 01, 2024	02-01
Transcript : Takeda Pharmaceutical Company Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM	01-08
Transcript : Takeda Pharmaceutical Company Limited, Q2 2024 Earnings Call, Oct 26, 2023	23-10-26
Transcript : Takeda Pharmaceutical Company Limited Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 03:55 PM	23-09-11
Transcript : Takeda Pharmaceutical Company Limited, Q1 2024 Earnings Call, Jul 27, 2023	23-07-27
Transcript : Takeda Pharmaceutical Company Limited, 2023 Earnings Call, May 11, 2023	23-05-11
Transcript : Takeda Pharmaceutical Company Limited - Special Call	23-03-18
Transcript : Takeda Pharmaceutical Company Limited - Special Call	23-03-15
Transcript : Takeda Pharmaceutical Company Limited Presents at Cowen 43rd Annual Healthcare Conference, Mar-06-2023 01:30 PM	23-03-06
Transcript : Takeda Pharmaceutical Company Limited, Q3 2023 Earnings Call, Feb 02, 2023	23-02-02
Transcript : Takeda Pharmaceutical Company Limited Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 04:30 PM	23-01-09
Transcript : Takeda Pharmaceutical Company Limited - Shareholder/Analyst Call	22-12-13
Transcript : Takeda Pharmaceutical Company Limited, Q2 2023 Earnings Call, Oct 27, 2022	22-10-27
Transcript : Takeda Pharmaceutical Company Limited - Special Call	22-10-04
Transcript : Takeda Pharmaceutical Company Limited Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 02:50 PM	22-09-12
Transcript : Takeda Pharmaceutical Company Limited, Q1 2023 Earnings Call, Jul 28, 2022	22-07-28
Takeda Pharmaceutical Company Limited Provides Consolidated Earnings Guidance for Year Ending March 31, 2023	22-07-28	CI
Transcript : Takeda Pharmaceutical Company Limited, Q4 2022 Earnings Call, May 11, 2022	22-05-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Takeda Pharmaceutical Company Limited London S.E.

Equities

0A87

US8740602052

Transcripts

Filters